These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39048649)

  • 1. Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer.
    Zhang H; Li Y; Lu H
    Sci Rep; 2024 Jul; 14(1):17084. PubMed ID: 39048649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma.
    Hao Q; Wu H; Liu E; Wang L
    BMC Cancer; 2023 Oct; 23(1):995. PubMed ID: 37853361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
    Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
    Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
    Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
    Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pan-Cancer Analysis of the Immunological and Prognostic Role of BUB1 Mitotic Checkpoint Serine/Threonine Kinase B (BUB1B) in Human Tumors.
    Huang W; Chen Z; Tang Y; Li J; Fan L
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of
    Zeng Q; Zhang S; He L; Fu Q; Liao L; Chen L; Ding X
    Cancer Biother Radiopharm; 2024 Apr; 39(3):236-246. PubMed ID: 37782908
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma.
    Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
    Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
    Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
    Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer.
    Zhou R; Liu M; Li M; Peng Y; Zhang X
    Transl Cancer Res; 2024 Sep; 13(9):4534-4554. PubMed ID: 39430818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
    BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis.
    Zhou X; Yuan Y; Kuang H; Tang B; Zhang H; Zhang M
    Bioengineered; 2022 Feb; 13(2):2471-2485. PubMed ID: 35068350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
    Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma.
    Qin LT; Huang SW; Huang ZG; Dang YW; Fang YY; He J; Niu YT; Lin CX; Wu JY; Wei ZX
    BMC Med Genomics; 2022 Dec; 15(1):272. PubMed ID: 36577966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer.
    Fu X; Chen G; Cai ZD; Wang C; Liu ZZ; Lin ZY; Wu YD; Liang YX; Han ZD; Liu JC; Zhong WD
    Onco Targets Ther; 2016; 9():2211-20. PubMed ID: 27143916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer.
    Li L; Xu DB; Zhao XL; Hao TY
    Arch Gynecol Obstet; 2013 Jul; 288(1):155-65. PubMed ID: 23334889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.
    Davidson B; Nymoen DA; Elgaaen BV; Staff AC; Tropé CG; Kærn J; Reich R; Falkenthal TE
    Virchows Arch; 2014 Jun; 464(6):701-7. PubMed ID: 24756216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
    Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
    Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BUB1b impairs chemotherapy sensitivity via resistance to ferroptosis in lung adenocarcinoma.
    Ding Y; Gao J; Chen J; Ren J; Jiang J; Zhang Z; Tong X; Zhao J
    Cell Death Dis; 2024 Jul; 15(7):525. PubMed ID: 39043653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
    Ko YH; Roh JH; Son YI; Chung MK; Jang JY; Byun H; Baek CH; Jeong HS
    J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.